San Diego, CA, United States of America

Philip Turnbull

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Location History:

  • Summit, NJ (US) (2021)
  • San Diego, CA (US) (2021 - 2022)

Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Philip Turnbull

Introduction

Philip Turnbull is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1 receptor modulators. With a total of three patents to his name, Turnbull's work has the potential to impact therapeutic practices significantly.

Latest Patents

Turnbull's latest patents include innovative compounds that modulate the glucagon-like peptide 1 (GLP-1) receptor. These compounds are designed for various applications, including methods of synthesis and therapeutic use. One of his notable patents involves the dimethylaminoethanol salt of a GLP-1 receptor modulator, which is a crystalline compound with specific structural characteristics. This invention aims to enhance the efficacy of treatments related to metabolic disorders.

Career Highlights

Philip Turnbull is currently associated with Receptos, Inc., where he continues to advance his research and development efforts. His work at the company focuses on creating novel therapeutic solutions that address critical health issues. Turnbull's dedication to innovation in the pharmaceutical industry is evident through his successful patent applications.

Collaborations

Throughout his career, Turnbull has collaborated with talented individuals such as Junko Tamiya and Adam Richard Yeager. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Philip Turnbull's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work on GLP-1 receptor modulators showcases the potential for innovative solutions in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…